Thyroid axis in patients with Cushing's syndrome

D. S. Duick

Archives of Internal Medicine · 1979 · 26 citations · 0 references

Concepts

Abstract

Thyroid hormone values and serum thyrotropin (thyroidstimulating hormone [TSH]) responses to the intravenous administration of 400 μg of protirelin were determined in ten patients with Cushing's syndrome and in ten matched normal subjects. In patients with Cushing's syndrome, the serum thyroxine (T<sub>4</sub>) level was mildly depressed and free T<sub>3</sub>level was normal. The mean ( ± SD) concentrations of serum triiodothyronine (T<sub>3</sub>) and free T<sub>3</sub>were both reduced in patients compared with normal subjects (<i>P</i>&lt;.001). At 20 and 60 minutes after protirelin administration, serum TSH levels were, respectively, 3.3 ± 2.7 μU/mL and 2.6 ± 2.3 μU/mL in patients with Cushing's syndrome and 12.3 ± 5.4 μU/mL and 10.7 ± 5.4 μU/mL in normal subjects (<i>P</i>&lt;.001). The reduced serum T<sub>3</sub>and free T<sub>3</sub>levels are due to a glucocorticoid suppressive effect on the peripheral conversion of T<sub>3</sub>to T<sub>3</sub>. The protirelin test is of limited value in assessing the thyroid status because the response of TSH is frequently blunted or absent due to glucocorticoid excess. (<i>Arch Intern Med</i>139:767-772, 1979)